BIO-based PDO 2026 market information review

BIO-BASE PDO

Bio-based PDO (Bio-based 1,3-Propanediol) — PTT Downstream, Capacity Landscape & Market Outlook (2026)

SEO keywords: bio-based PDO, 1,3-propanediol, fermentation route, PTT, PTT fiber, Sorona®, Primient, CovationBio, capacity expansion, oversupply risk, bio-based materials

One-line takeaway

Bio-based PDO enables a “fermentation-over-petrochem” pathway for greener materials; PTT fiber is the largest value sink, while 2026 marks a critical window where capacity growth must be matched by demand realization.

What you’ll get

✅ Understand the PDO → PTT chain
✅ Decode CovationBio’s exit & capacity repricing
✅ Track key trends for 2026–2030

Quick navigation

What is PDO? Downstream Event Capacity map Exit drivers Outlook FAQ

1) What is Bio-based PDO (Bio-based 1,3-Propanediol)?

Bio-based PDO, short for bio-based 1,3-propanediol, is an organic compound produced via biological fermentation rather than conventional petrochemical routes. Its feedstock origin and process pathway are widely recognized for greener and more sustainable characteristics—making PDO a key “platform” building block in the bio-based chemicals value chain.

✅ Sustainability angle

Fermentation pathways can use glucose and/or glycerol-based routes, reducing reliance on petrochemical inputs and improving low-carbon narratives.

✅ Industrial positioning

As a diol monomer, PDO bridges multiple industries—polyesters, polyurethanes, personal care, and specialty formulations—creating cross-sector demand potential.

2) Largest downstream: PDO → PTT (Polytrimethylene Terephthalate)

The largest downstream application for bio-based PDO is as a monomer that polymerizes with purified terephthalic acid (PTA) to produce a high-performance polyester: polytrimethylene terephthalate (PTT). PTT is then further processed into PTT fibers.

PTT fiber (core application) — key performance advantages

• Excellent stretch & recovery: Comparable to spandex in feel, yet typically more durable and less prone to aging.
• Softer handfeel: Often softer than PET (polyester) and nylon.
• Easier dyeing: Atmospheric boil dyeing enables vivid colors with potential energy savings.
• Stain & wrinkle resistance: Simplifies everyday care and maintenance.

Representative products & brands

A well-known PTT fiber brand based on bio-based PDO is DuPont’s Sorona® (with roughly 37% plant-derived content in its core polymer).

Application markets (high-value end uses)

Premium sportswear, yoga apparel, underwear, swimwear, carpets, and home textile upholstery fabrics.

3) Other important applications (multi-industry penetration)

Polyurethanes (PU)

Used as a polyol component to produce more eco-friendly PU foams, coatings, adhesives, and elastomers.

Cosmetics & personal care

Functions as a humectant and solvent in skincare and cosmetic formulations, with a strong safety profile.

Antifreeze / coolants

Supports biodegradable, environmentally preferred coolant systems.

Composites & engineering plastics

Enables performance enhancement pathways for reinforced plastics and higher-durability applications.

4) Event background: CovationBio exits bio-based PDO (2026-01-14)

On January 14, 2026, CovationBio (under Huafon Group) announced the sale of its entire stake in Primient Covation, formally exiting the world’s largest bio-based PDO (1,3-propanediol) production business. The transaction involves a Tennessee, USA plant with 77,000 t/y capacity. Upon completion, Primient will fully own this business (100% control).

Context: asset origin & technology pathway

In 2022, Huafon Group acquired certain DuPont business assets, including two U.S. manufacturing bases: one associated with the well-known brands Susterra® and Zemea®, focused on bio-based PDO used in high-performance, more degradable polyester plastics; another base focused on bio-based specialty polyester fiber material PTT. DuPont first developed and commercialized the PTT technology around 2000, with key end-use markets in apparel and carpets.

5) Capacity expansion wave: China’s bio-based PDO landscape (as of end-2025)

Key notes (as of end-2025)

• Total China bio-based PDO capacity: approximately 150–180 kt/y.
• Top players (Huaheng Bio, Tsingda Zhixing, Hengtane Tech, Wanhua Chemical—planned, etc.) represent 70%+ of the total, indicating strong concentration.
• Dominant process route: fermentation (glucose/glycerol) at ~85%; chemical routes continue to decline due to environmental pressure.
• Capacity clusters: East China (Jiangsu, Shandong) and North China (Inner Mongolia, Shanxi).

Note: CovationBio’s 77 kt/y PDO business was sold in January 2026 and is therefore excluded from the “current China-layout list” here.

Company	Process route	Capacity (kt/y)	Main sites	Key notes
Huaheng Bio	Fermentation (glucose/glycerol)	50–80	Anhui; Chifeng (Inner Mongolia)	Largest fermentation-based PDO producer in China; 50 kt/y Chifeng line started in May 2024
Tsingda Zhixing	Fermentation (multi-feedstock)	32	Liangshan (Shandong); Changzhi (Shanxi)	Dual routes: glycerol + sugar; 20 kt/y sugar-route unit commissioned in 2022
Hengtane Tech	Fermentation (non-grain feedstock)	15	Jinan (Shandong)	“Three-Non” route (non-grain, non-GMO, non-fossil); started in 2025
Wanhua Chemical	Fermentation	50 (planned)	Yantai (Shandong)	Integrated petrochemical advantages; project announced in 2025, expected start-up in 2026
Eastern Shenghong	Fermentation	30 (planned)	Lianyungang (Jiangsu)	Integrated advantages; paired with PTT downstream project
Juhua Co.	Fermentation	20 (planned)	Quzhou (Zhejiang)	Progressing alongside a PDO–PTT integration roadmap

2025 new entrants / expansions (construction or planning)

• Yifeng Jiatai (Mudanjiang): 30 kt/y, fermentation route, expected 2026; EIA disclosure in Dec 2025
• Shandong Xiangchi Jianyuan: 20 kt/y (revamp), fermentation route, expected 2026; revamping an erythritol workshop
• Other SMEs: total ~50–80 kt/y, bio/chemical routes, 2026–2027; multi-region pipeline

International players (China-market perspective)

• DuPont: technology licensor; has exited direct manufacturing
• BASF / Dow: focused on downstream applications; no major PDO production build-out reported
• Primient: now the world’s largest PDO producer via acquiring CovationBio’s stake (77 kt/y), primarily supplying overseas markets

6) Three drivers behind CovationBio’s exit

Driver 1: Focus on core arenas & resource optimization

Huafon’s strengths lie more in downstream materials such as polyurethane and spandex rather than upstream monomers. PDO is mature but relatively slow-growing and management-intensive. Exiting allows capital and attention to shift toward higher-growth, higher value bio-based projects such as bioPTMEG (reported 500 kt/y project in Qidong, Jiangsu), supporting a lighter-asset approach.

Driver 2: Oversupply cycle & price-war risk management

2025 has been called the “groundbreaking year” for PDO projects, yet supply–demand imbalances have already surfaced. On commonly cited industry estimates, global bio-based PDO demand in 2025 was about 180 kt, while existing plus under-construction capacity exceeded 350 kt. The 2026–2027 period may face at least 100 kt of oversupply pressure, increasing the probability of margin compression and price competition.

Driver 3: Technology iteration window — next-gen materials

Bio-based PDO technology is becoming more standardized and barriers are declining. Meanwhile, Huafon is advancing commercialization of bioPTMEG (reported start-up around 2026), which could substitute petroleum-based PTMEG with a larger addressable market. Exiting PDO can free funds for more forward-looking bio-based material R&D, consistent with “exit non-core, focus on high-value” strategy.

Additional viewpoint: The author suggests a more direct reason could be geopolitical considerations (e.g., China–U.S. relations), with the exit reducing exposure to future uncertainties tied to U.S.-based investments.

7) Oversupply risk: key challenges expected in 2026

(1) Supply–demand imbalance signals

Estimated average capacity utilization in 2025 was ~75%, with some players below 60%. Competitive pressure increased and PDO prices in 2025 were estimated ~15% lower than 2023 levels, with inventory pressure rising. If additional capacity ramps on schedule in 2026, price competition may intensify.

(2) Longer payback cycles

Payback expectations for new projects have stretched from ~3 years to 5+ years. For a representative 30 kt/y project under current pricing assumptions, the payback period was estimated at ~5.2 years—about 1.8 years longer than 2023. Some SMEs may exit or become acquisition targets due to financing pressure.

(3) Can downstream demand keep up?

Major downstreams include PTT fibers, cosmetics, and pharmaceutical intermediates. While a 13.1% CAGR is often cited for PTT, 2025 realized demand growth was around 8%—slower than capacity expansion. If new applications scale more slowly than expected, oversupply pressure could further build.

8) Company strategies: how to win in a capacity-heavy cycle

Strategy 1: Differentiate through technology routes

Leading players can build moats via strain/process iteration: examples cited include Huaheng Bio (fermentation titer up to 110 g/L), Tsingda Zhixing (multi-feedstock switching), and Hengtane Tech (“Three-Non” route), all targeting cost-down and efficiency gains. New entrants should assess their technical defensibility to avoid commoditization.

Strategy 2: Integrate downstream

Producing PDO alone exposes businesses to price swings. Extending into PTT and bio-based spandex can increase value capture. “PDO–PTT” integration (e.g., by Eastern Shenghong and Juhua) can internalize feedstock economics and improve resilience.

Strategy 3: Break into premium grades

Medical-grade and cosmetic-grade PDO still lean on imports in many segments; the author suggests DuPont and BASF hold ~85% share. If domestic players achieve ultra-high purity (≥99.99%) and complete required certifications, they may avoid low-end price wars and capture premium margins. Certification cycles, however, are typically lengthy.

Strategy 4: Rational capacity control

With potential oversupply in 2026, companies should align expansions with capital strength, technical edge, and market positioning. Some projects have already reportedly delayed start-up schedules (e.g., a 50 kt/y project planned for 2026 postponed to 2027).

9) Outlook: industry trends for 2026–2030

Short-term (2026–2027)

• Consolidation may not accelerate immediately: many entrants have strong capital bases; peak capacity may arrive within two years.
• Price competition likely continues: cost-advantaged producers may win via upgrades and operational excellence.
• Downstream application expansion: cosmetics and pharma intermediates may add incremental demand, but scaling requires time.

Long-term (2028–2030)

• Non-grain feedstock breakthroughs: straw and waste-derived routes could reshape cost structures.
• Policy tailwinds persist: decarbonization goals can lift adoption, while carbon taxes and compliance costs may influence economics.
• Next-gen materials: bioPTMEG, PEF, and other platforms may emerge as new growth engines.

10) Conclusion: rational thinking amid the capacity wave

CovationBio’s exit from PDO reflects both a company-level strategic adjustment and a broader industry phase shift. The “project landing year” of 2025 accelerated capacity growth, while also planting the seeds of oversupply. The author expects a “reshuffle” period around 2032, where firms with strong technology, disciplined cost control, and deeper downstream integration will stand out—while weaker players may be phased out. Investors and practitioners should balance long-term optimism for bio-based materials with near-term caution around supply–demand mismatches. Ultimately, technology and value creation will determine winners in this transition.

FAQ — Bio-based PDO & PTT Fiber

What is the key difference between bio-based PDO and petro-based PDO?

The core difference lies in feedstock origin and production route. Bio-based PDO commonly uses fermentation, supporting sustainability and low-carbon narratives. Petro-based PDO relies on petrochemical feedstocks and faces higher environmental compliance pressure.

Why is PTT fiber considered the largest downstream for PDO?

PDO can polymerize with PTA to form PTT, which can be melt-spun into high-performance fibers used in premium apparel and carpets. This monomer-to-material chain is a primary value conversion pathway.

What is the biggest industry risk in 2026?

The biggest risk is oversupply-driven margin compression. If new capacity ramps faster than downstream demand, price competition may intensify and industry differentiation will accelerate.

Need more market data or a customized interpretation of the bio-based PDO / PTT chain?

Optional add-ons: price ranges, premium-grade specifications, cosmetic/medical compliance & certifications, supplier landscape, start-up timelines, and downstream brand/application case studies.

Email inquiry in one click